Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes

Ferroptosis as a target for protection against cardiomyopathy

(2019) Xuexian Fang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Engineering human ventricular heart tissue based on macroporous iron oxide scaffolds

(2019) Hui Yang et al.   Acta Biomaterialia

Co-loading antioxidant N-acetylcysteine attenuates cytotoxicity of iron oxide nanoparticles in hypoxia/reoxygenation cardiomyocytes

(2019) Yunli Shen et al.   International Journal of Nanomedicine

Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes

(2019) Tae-Jun Park et al.   Cell Death & Disease

Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes

(2018) Yuichi Baba et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Pathological Roles of Iron in Cardiovascular Disease

(2018) Motoi Kobayashi et al.   CURRENT DRUG TARGETS

New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles

(2018) Massimiliano Magro et al.   CURRENT MEDICINAL CHEMISTRY

Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update

(2018) Richard Gordan et al.   HEART FAILURE REVIEWS

Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages

(2018) Liu Liu et al.   ACS Applied Materials & Interfaces

Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors

(2018) Zheyu Shen et al.   ACS Nano

Visualising inflammation after myocardial infarction with the use of iron oxide nanoparticles

(2017) Ali Yilmaz   HEART

Characterization of ferroptosis in murine models of hemochromatosis

(2017) Hao Wang et al.   HEPATOLOGY

Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment–Elevation Myocardial Infarction and Adverse Left Ventricular RemodelingCLINICAL PERSPECTIVE

(2016) Heerajnarain Bulluck et al.   Circulation-Cardiovascular Imaging

Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial InfarctionCLINICAL PERSPECTIVE

(2016) David Carrick et al.   Circulation-Cardiovascular Imaging

Reduction in mitochondrial iron alleviates cardiac damage during injury

(2016) H.-C. Chang et al.   EMBO Molecular Medicine

Comparison of Magnetic Intensities for Mesenchymal Stem Cell Targeting Therapy on Ischemic Myocardial Repair: High Magnetic Intensity Improves Cell Retention but Has no Additional Functional Benefit

(2015) Yunli Shen et al.   CELL TRANSPLANTATION

Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles

(2015) Yunli Shen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice

(2015) Abderrahim Nemmar et al.   Particle and Fibre Toxicology

Superparamagnetic iron oxide nanoparticles exacerbate the risks of reactive oxygen species-mediated external stresses

(2014) Cheng Luo et al.   ARCHIVES OF TOXICOLOGY

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

(2014) Yoshihiko Ichikawa et al.   JOURNAL OF CLINICAL INVESTIGATION

The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation

(2013) Zheyong Huang et al.   BIOMATERIALS

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

(2012) Scott J. Dixon et al.   CELL

Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles

(2011) Mohd Imran Khan et al.   BIOMATERIALS

Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress

(2010) Naqvi et al.   International Journal of Nanomedicine

Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction

(2009) J. Ganame et al.   EUROPEAN HEART JOURNAL